Monarch Medical Technologies Receives FDA 510(k) Clearance for EndoTool SubQ™

Business News
Print
CHARLOTTE, N.C.--(BUSINESS WIRE)--Monarch Medical Technologies, a medical technology company committed to safe insulin dosing, today announced that the US Food and Drug Administration (FDA) has cleared the company's newest solution, EndoTool SubQ™. “The FDA 510(k) Clearance of our newest solution comes at a critical time for hospitals and for Monarch. Today, more patients than ever require insulin during their hospitalizations. While insulin remains one of the most dangerous drugs to dose, our

imageimage
image

Read more